MedTrace Logo

Study of Lyme Neuroborreliosis

NCT01635530 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2019-05-13

No results posted yet for this study

Summary

The main purpose of this study is to determine whether four weeks treatment with oral doxycycline is as equally effective as three weeks treatment with intravenous ceftriaxone in patients with Lyme neuroborreliosis. The other purpose is to improve laboratory diagnostics of Lyme neuroborreliosis and further define the manifestations and epidemiology of the disease in Finland.

Conditions

  • Lyme Neuroborreliosis

Interventions

DRUG

Doxycycline

Doxycycline: 100mg tablet two times per day, four weeks

DRUG

Ceftriaxone

2 g intravenous once a day, three weeks

Sponsors & Collaborators

  • Turku University Hospital

    lead OTHER_GOV

Principal Investigators

  • Jukka Hytönen · University of Turku

  • Elisa Kortela · HYKS

  • Mari Kanerva · HYKS

  • Laura Airas · TYKS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01635530 on ClinicalTrials.gov